The Patent Finder

Olon S.P.A.

21 patents currently held · Updated Nov 15, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Dec 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 2 to 25, 2026 · next Dec 2
  • 2 fees due May 21 to 26, 2027 · next May 21
  • 1 fee due Jul 21, 2027
    The maintenance fee for Process for the preparation of indanamine derivatives and new synthesis intermediates (US 10,538,479) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives (US 9,315,541) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026
  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,935,818Process for the preparation and purification of valgancyclovir hydrochloride
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,519,160Process for the preparation of rotigotine
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,313,922Process for the production of daptomycin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,447,109Crystalline salts of asenapine
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,045,515Procedure for the purification of tiacumicin B
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,970,041Procedure for the production of tiacumicin B
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,340,571Process for the purification of abiraterone acetate
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,556,219Procedure for the preparation of abiraterone acetate and intermediates thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,630,987Procedure for the preparation of abiraterone acetate and intermediates thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,315,541Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
Also on record, not counted in the 21: 2 patents in force now held by others · 10 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 2 abandoned · 16 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited